- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
多柔比星是一种蒽环类抗肿瘤抗生素,可通过诱导DNA双链断裂抑制DNA拓扑异构酶Ⅱ。1 多柔比星嵌入DNA链后,会抑制核酸合成,并通过促使p53肿瘤抑制蛋白积累诱导细胞凋亡。2
Technical Information
Formal Name
(8S,10S)-
10- [(3- amino- 2,3,6- trideoxy- α- L- lyxo- hexopyranosyl)oxy]- 7,8,9,10- tetrahydro- 6,8,11- trihydroxy- 8- (2- hydroxyacetyl)- 1- methoxy- 5,12- naphthacenedione, monohydrochloride CAS Number
25316-40-9
Synonyms
- DOX
Molecular Formula
C27H29NO11 • HCl
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
Solubility
DMSO: 10 mg/mlDMSO:PBS (pH 7.2) (1:1): 0.5 mg/mlEthanol: 1 mg/mlPBS (pH 7.2): >100 µg/ml
λmax
234, 252, 288, 479 nm
SMILES
OC1=C(C[C@](C(CO)=O)(O)C[C@@H]2O[C@@](O[C@@H](C)[C@H]3O)([H])C[C@@H]3N)C2=C(O)C(C4=O)=C1C(C5=CC=CC(OC)=C45)=O.Cl
InChi Code
InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1
InChi Key
MWWSFMDVAYGXBV-RUELKSSGSA-N
关键词:- 盐酸多柔比星
-
产品组分
组分内容
型号
规格
储存温度
盐酸多柔比星
15007
5mg
-20°C 操作手册 1
1
常温
-
文件资源
文件下载 文件内容 资源说明 
15007-盐酸多柔比星 操作手册 
15007-盐酸多柔比星相关说明 宣传单页 -
注意事项
保存建议 推荐蓝冰或冰袋运输。当您收到产品后,按照说明书建议保存各组分。 -
FAQ

-
Product Description References
1. Patel, S., Sprung, A.U., Keller, B.A., et al. Identification of yeast DNA topoisomerase II mutants resistant to the antitumor drug doxorubicin: Implications for the mechanisms of doxorubicin action and cytotoxicity. Mol. Pharmacol. 52(4), 658-666 (1997).
2. Lorenzo, E., Ruiz-Ruiz, C., Quesada, A.J., et al. Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-
dependent mechanism. The Journal of Biological Chemisty 277(17), 10883-10892 (2002). Product Citations
Wong, F., Zheng, E.J., Valeri, J.A., et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626(7997), 177-185 (2024).
Du, W., Gu, M., Hu, M., et al. Lysosomal Zn2+ release triggers rapid, mitochondria-
mediated, non- apoptotic cell death in metastatic melanoma. Cell Rep. 37(3), 109848 (2021). Yousefi, B., Azimi, A., Majidinia, M., et al. Balaglitazone reverses P-
glycoprotein- mediated multidrug resistance via upregulation of PTEN in a PPARγ- dependent manner in leukemia cells. Tumour Biol. 39(10), (2017). Meyer, F.B., Goebel, S., Spangel, S.B., et al. Metformin alters therapeutic effects in the BALB/c tumor therapy model. BMC Cancer 21(1), 629 (2021).
猜你喜欢
在线留言
如果您对我们的产品感兴趣,请留下您的信息,我们将尽快与您联系,谢谢!
艾维缔官网
艾德官网
B站IVDSHOW
抖音军哥聊表观
视频号艾维缔
小红书艾维缔
快手表观盒子
表观遗传学
联系我们
